You’re invited to an upcoming event entitled “NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) Informational Webinar”, occurring on December 16th from 12-1pm ET. Dr. Sophie Cho and Joan Ohayon, along with our esteemed panel, will provide an update to recently reissued Notice of Funding Opportunity (NOFO) for the NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional): PAR-25-133. NeuroNEXT provides robust, standardized, and accessible infrastructure, designed to facilitate the development and conduct of Phase 2 clinical trials or biomarker studies focused on neurological diseases in pediatric and adult populations. The webinar will provide information on new updates in the NeuroNEXT Small Business Innovation Opportunity.
Visit our Event Page!
We hope you can join us!